Roth MKM lowered the firm’s price target on Emeren (SOL) to $2 from $3 and keeps a Buy rating on the shares following a Q4 miss and “weak” 2025 outlook. The firm remains cautious as project pushouts continue to be a risk and needs to see consistent execution in order to have confidence that the stock can trade closer to the company’s net asset value of $5.90 per share, says the analyst, who cites valuation for the firm’s continued Buy rating.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOL:
